絞り込み

16639

広告

里山のチョウ類が激減 耕作放棄地増加などが影響か 環境省 (NHK)

里山などに生息するチョウ類のうち、ミヤマカラスアゲハなど34種の数が急速に減少していることが環境省などの調査でわかりました。 環境省と日本自然保護協会は大学や住...

  1. [医学] 異常をきたすと癌を生じやすくす...
  2. 松本零士さん快方へ 病院側「意識戻った」...
  3. 第160回 夜中に台所でバナナをかじった...
  4. 古代エジプトに大量の鳥ミイラの謎、異説が...

ニュース一覧

スターを付ける スターを付ける     (10view , 0users)

Full Text Sources

Miscellaneous

Osteolytic bone lesions and hypercalcemia are common, serious complications in adult T cell leukemia/lymphoma (ATL), an aggressive T cell malignancy associated with human T cell leukemia virus type 1 (HTLV-1) infection. The HTLV-1 viral oncogene HBZ has been implicated in ATL tumorigenesis and bone loss. In this study, we evaluated the role of HBZ on ATL-associated bone destruction using HTLV-1 infection and disease progression mouse models. Humanized mice infected with HTLV-1 developed lymphoproliferative disease and continuous, progressive osteolytic bone lesions. HTLV-1 lacking HBZ displayed only modest delays to lymphoproliferative disease but significantly decreased disease-associated bone loss compared with HTLV-1-infected mice. Gene expression array of acute ATL patient samples demonstrated increased expression of RANKL, a critical regulator of osteoclasts. We found that HBZ regulated RANKL in a c-Fos-dependent manner. Treatment of HTLV-1-infected humanized mice with denosumab, a monoclonal antibody against human RANKL, alleviated bone loss. Using patient-derived xenografts from primary human ATL cells to induce lymphoproliferative disease, we also observed profound tumor-induced bone destruction and increased c-Fos and RANKL gene expression. Together, these data show the critical role of HBZ in driving ATL-associated bone loss through RANKL and identify denosumab as a potential treatment to prevent bone complications in ATL patients.
PMID: 31578308 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード